Next read this
Greg Freiherr currently reports on medical issues for magazines and websites, and consults for vendors of medical equipment. He serves as U.S. consulting editor for Diagnostic Imaging Europe, contributing editor for Imaging Technology News, and contributing editor for the Smithsonian’s Air & Space magazine. Mr. Freiherr has recently served as a consultant to Siemens Healthcare, Carestream Health, Abbott Laboratories and JP Morgan. He has also served as features editor for Oncology News International, business and technology editor for Diagnostic Imaging magazine, editor of the online newsletter DI SCAN, and contributing editor to Medscape.
Freiherr has reported for more than 30 years on developments in medical technology ranging from in vitro and in vivo diagnostics to drug and radiation therapies, working initially as a contributing editor for a variety of magazines and serving with a private consulting firm in the Washington, D.C. area for components of the National Institutes of Health, notably the National Cancer Institute and National Center for Research Resources.
Through his own firm, he has consulted for global corporations, including Siemens, Carestream, GE, Bracco Diagnostics and Toshiba. He has also consulted for such public agencies as NASA; academia including the Harvard Medical School and The Wistar Institute; and private financial concerns, including Merrill Lynch and Chemical Bank. He has contributed as an industry expert for trade publications, the Wall Street Journal and New York Times. Early in his career he was a deputy division director of a government contracting firm that held multiple contracts with the NIH, FDA, and EPA. He holds a bachelor of science degree from the UW-Madison.
The opinions expressed in this blog are those of Greg Freiherr and do not necessarily represent those of IDG Communications, Inc., its parent, subsidiary or affiliated companies.